Also, the effect appeared to be independent of vascular risk factors, suggesting that the diet had non-vascular protective benefits, such as antioxidant or anti-inflammatory properties, they wrote.
And in a separate study, published by Swedish researchers in the October issue of Archives of Neurology, there was also evidence that dietary supplements containing a prominent Mediterranean diet component -- omega-3 fatty acids -- may reduce the rate of cognitive decline in people with the mildest Alzheimer's disease. Omega-3 didn't seem to slow the progression of more advanced forms of the dementia, they added.
Aricept Indications Expanded
Aricept (donepezil), one of the few available agents against Alzheimer's disease, received an expanded indication from the FDA in October.
A cholinesterase inhibitor on the market for mild to moderate Alzheimer's disease, Aricept became the first of its class to win FDA approval for severe disease, and the action made Aricept the only drug approved to treat all stages of Alzheimer's.
